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for the Interventional Cardiologists at Quebec Heart-Lung Institute
Quebec City and Montreal, Quebec, CanadaObjectives This study sought to determine the efﬁcacy of low rate ﬂuoroscopy at 7.5 frames/s (FPS)
versus conventional 15 FPS for reduction of operator and patient radiation dose during diagnostic
coronary angiography (DCA) and percutaneous coronary intervention (PCI) via the transradial
approach (TRA).
Background TRA for cardiac catheterization is potentially associated with increased radiation
exposure. Low rate ﬂuoroscopy has the potential to reduce radiation exposure.
Methods Patients undergoing TRA diagnostic angiography  ad-hoc PCI were randomized to
ﬂuoroscopy at 7.5 FPS versus 15 FPS prior to the procedure. Both 7.5 and 15 FPS ﬂuoroscopy protocols
were conﬁgured with a ﬁxed dose per pulse of 40 nGy. Primary endpoints were operator radiation
dose (measured with dosimeter attached to the left side of the thyroid shield in mSievert [mSv]), patient
radiation dose (expressed as dose-area product in Gy$cm2), and ﬂuoroscopy time.
Results From October 1, 2012 to August 30, 2013, from a total of 363 patients, 184 underwent DCA
and 179 underwent PCI. Overall, ﬂuoroscopy at 7.5 FPS compared with 15 FPS was associated with a
signiﬁcant reduction in operator dose (30% relative reduction [RR], p < 0.0001); and in patient’s dose-
area product (19% RR; p ¼ 0.022). When stratiﬁed by procedure type, 7.5 FPS compared with 15 FPS
was associated with signiﬁcant reduction in operator dose during both DCA (40% RR; p < 0.0001) and
PCI (28% RR; p ¼ 0.0011). Fluoroscopy at 7.5 FPS, compared with 15 FPS, was also associated with
substantial reduction in patients’ dose-area product during DCA (26% RR; p ¼ 0.0018) and during PCI
(19% RR; p ¼ 0.13). Fluoroscopy time was similar in 7.5 FPS and 15 FPS groups for DCA (3.4  2.0 min
vs. 4.0  4.7 min; p ¼ 0.42) and PCI (11.9  8.4 min vs. 13.3  9.7 min; p ¼ 0.57), respectively.
Conclusions Fluoroscopy at 7.5 FPS, compared with 15 FPS, is a simple and effective method
in reducing operator and patient radiation dose during TRA DCA and PCI. (J Am Coll Cardiol Intv
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568Transradial approach (TRA) is increasingly adopted
worldwide for cardiac catheterization and interventions due
to its lower vascular and bleeding complications (1–4),
improved patient comfort, early ambulation and hospital
discharge (5), and lower procedural cost (6). A potential
drawback of TRA, compared with transfemoral approach
(TFA), is increased radiation exposure to both operator and
patient (7–9), although some of the published studies
comparing the 2 approaches have been criticized for their
methodological ﬂaws (10–12). In addition, it is thought that
interventional cardiologists are among the medical personnel
with the highest exposure to ionizing radiation (13–15).
Some studies estimated the exposure per head per year of
interventional cardiologists to be 2 to 3 higher than that
of radiologists. According to recent registries, contemporary
experienced interventional cardiologists in high-volume
centers have an annual exposure equivalent to 5 mSv per year
and a non-negligible professional lifetime attributable risk ofAbbreviations
and Acronyms
DAP = dose area product
DCA = diagnostic coronary
angiography
EPD = electronic personal
dosimeter
FPS = frames per second
LRA = left radial artery
PCI = percutaneous
intervention
RR = relative reduction
RRA = right radial artery
TFA = transfemoral approach
TRA = transradial approachcancer (16). Radiation exposure,
among many other factors, is
strongly inﬂuenced by operator
expertise (17–19), and it has been
estimated that trainees receive
60% more radiation in their ﬁrst
year of training than in their
second year, presumably due to
longer ﬂuoroscopy time to posi-
tion catheters. Therefore, keep-
ing with the “as low as reasonably
achievable” principle, it remains
crucial to take all possible mea-
sures to reduce operator and pa-
tient radiation exposure.
The effect of lower rate ﬂuo-
roscopy on radiation exposure
during TRA has not beeninvestigated. In this study, we aimed to evaluate the efﬁcacy
of low rate ﬂuoroscopy at 7.5 frames/s (FPS) compared with
conventional 15 FPS, in reducing operator and patient ra-
diation dose during TRA diagnostic coronary angiography
(DCA) and percutaneous coronary interventions (PCI).
Methods
Study design and cohort. Our center has used TRA as a
default access site for 20 years. Over the years, changes in
radiation protection measures have been developed and
better imaging equipment have been acquired, but no
change in image acquisition has been evaluated. This project
was therefore conceived and discussed with operators as part
of a quality control program to further optimize and reduce
radiation exposure. Patients undergoing elective, urgent, or
emergent cardiac catheterization procedures with or without
ad-hoc PCI, via TRA from October 1, 2012, to August 30,2013 were eligible. Exclusion criteria were non-TRA access
and participation in research project(s) requiring higher (i.e.,
30 FPS) cine angiography. This study was approved by the
institutional review board, and all patients signed an
informed consent prior to the procedure. The study was
registered at clinicaltrials.gov (NCT01990924).
Randomization. Using a computer-generated list and
opaque sealed envelopes, all procedures were randomly
allocated 1:1 to low rate ﬂuoroscopy at 7.5 FPS or standard
pulsed ﬂuoroscopy at 15 FPS. All procedures were per-
formed in the same angiographic room using a digital
single-plane Siemens Artis dFc ﬂuoroscopy system,
equipped with software (version VB35D, Siemens Medical
Systems, Forchheim, Germany). Both 7.5 and 15 FPS
ﬂuoroscopy protocols were conﬁgured with a ﬁxed dose per
pulse of 40 nGy (set by the manufacturer and the medical
physicist). All other user-adjustable technical parameters
(e.g., copper ﬁltration and pulse width) were also set at the
same values for both frame rates. All image cine acquisi-
tions were recorded at 15 FPS for both groups to avoid
quality issues between examinations.
Cardiac catheterization and PCI. Operators included 4
interventional cardiology fellows (intermediate- to high-
volume TRA operators; 700 to 1,400 TRA-PCI procedures)
and an experienced attending physician (high-volume
TRA operator: case load >200 TRA-PCI/annum). The
right radial artery (RRA) was the default access, and the
left radial artery (LRA) was used in case of prior coronary
artery bypass graft with a left internal mammary artery
graft, or if RRA was clinically occluded. TRA catheteriza-
tion and PCI were performed using standard techniques
as previously described (5,20). Although no standardized
views were deﬁned per protocol, a minimum of 4 to 6 views
were obtained to image the left coronary system and 2 to 3
views were obtained for the right coronary artery for DCA.
To represent usual practice, operators were left to obtain
more views with additional projections when necessary.
When performed, left ventriculography was recorded in the
right anterior oblique (RAO) projection, using an angulated
pigtail catheter and a remote-controlled mechanical contrast
injector with contrast volume set to 36 ml at 12 ml/s.
Aortography was performed in left anterior oblique (LAO)
45 projection. During PCI, the views and angulations were
left to the operator’s discretion.
Radiation protection. All operators adhered to standard
radiation protection procedures. Each operator wore a
2-piece lead apron, a thyroid shield, and leaded glasses. A
ceiling-suspended lead acrylic transparent shield (1-mm lead
equivalent; MAVIG, Munich, Germany) was pulled down
to the patient’s abdomen (Fig. 1A). An under-table pivotal
leaded shield offering the same radiation protection was
mounted to the side of the table (Fig. 1B). The patient’s
right arm (in case of RRA access) was fully adducted and
brought to the patient’s side after insertion of radial sheath.
Figure 1. Radiation Protection Equipment and EPD
Standard radiation protection equipment installed. (A) Ceiling-suspended acrylic shielding (1-mm lead equivalent), and (B) table-to-ﬂoor lead ﬂap. (C) Electronic
personal dosimeters (EPD) worn by operators. EPD was worn on the left side of the thyroid lead shield and the recorded dose absorbed by the operator during
each case. (D) EPD screen display.
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569A special unleaded arm board maintained the arm alongside
the patient’s body during the procedures (this arm board was
shown to reduce operator exposure by 10% to 20% in pre-
vious experience, data not shown). In the case of LRA, the
left arm was adducted and positioned over the patient’s
trunk. Beside conventional measures, operators were
encouraged to take advantage of “ﬂuoroscopy store” mode.
Radiation measurements. Operator radiation exposure
(mSv) was assessed using electronic personal dosimeters
(EPD) (model EPD Mk2, Thermo Scientiﬁc, Reading,
United Kingdom) with diode-based technology (Figs. 1B
and 1C). For every procedure, the dosimeter was attached
over the operator’s thyroid collar (left side). The operator
dose for every procedure was read once a week with an
infrared reader and the Easy EPD2 utility software (Thermo
Scientiﬁc). The effective dose delivered to patients was
directly measured by the diamentor on the x-ray tube of the
angiographic system and expressed as dose-area product
(DAP) in Gy$cm2.
Procedural duration was deﬁned as the time elapsed from
local anesthetic inﬁltration to removal of radial sheath upon
completion of the procedure. Operator dose, patient DAP,
procedural duration, contrast volume, and ﬂuoroscopy time
(min) were recorded after each procedure.
Primary and secondary endpoints. Primary endpoints were
operator radiation dose, patient radiation dose, expressed as
DAP, and ﬂuoroscopy time. Secondary endpoints were
procedural duration and contrast volume.
Statistical analysis and sample size. Sample size calculations
were based on observational data from our cardiac cathe-
terization laboratories over a 12-month period. Average
operator radiation doses per procedure were 30  20 mSv
for DCA and 65  25 mSv for PCI. The average patient’sDAP during the same period was 30  14 Gy$cm2 for
DCA and 75  35 Gy$cm2 for PCI. We estimated that a
sample size of 350 patients would be required to demon-
strate a 20% dose reduction in operator and patient
exposure with 7.5 FPS compared with 15 FPS during DCA
and/or PCI with a power of 80% at alpha level of 0.05.
Categorical variables are expressed as numbers and per-
centages, and continuous variables as mean  SD (medians
and interquartile ranges are also reported when appropriate).
Skewed data were log-transformed prior to statistical anal-
ysis to improve normality although untransformed values are
given in the tables and ﬁgures for clarity. Homogeneity of
variance was assessed by the Brown-Forsythe test. Differ-
ences between the 2 groups were evaluated using the Fisher
exact test or chi-square test for categorical variables and
Student t test for continuous variables. A p value <0.05 was
considered statistically signiﬁcant. Statistical analyses were
performed using JMP (version 10.0, SAS Institute, Cary,
North Carolina).
Results
Of the 385 patients undergoing cardiac catheterization
procedures during the study period, 363 were performed via
TRA and were included in the current analysis. The
remaining 22 patients were excluded due to pre-speciﬁed
exclusion criteria (Fig. 2). Baseline characteristics are out-
lined in Table 1. Mean age of study population was 65  11
years, 70% were male, with an average height of 168  10
cm, and body mass index of 29  6 kg/m2. Baseline char-
acteristics were similar in both groups (Table 1). Procedural
characteristics revealed no difference between the 2 ran-
domized groups in the number of cases performed by a
Figure 2. Study Flowchart
DCA ¼ diagnostic coronary angiography; FPS ¼ frames per second; PCI ¼ percutaneous coronary intervention; TFA ¼ transfemoral approach.
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570fellow or an experienced attending physician, access site
(RRA [91%] vs. LRA [9%]), procedural type, and the per-
centage of patients in whom left ventricular angiography
and aortography were performed (Table 2). One hundred
and eighty-four patients underwent DCA, with or without
left ventricular angiography and 179 underwent ad-hoc
PCI (Fig. 2). In the PCI group, 58% of cases had 1 type
B2 or C lesions, and a number of patients underwent
complex procedures, including bifurcational PCI in 19%,
antegrade recanalization of chronic total occlusions in 7%,
and rotational atherectomy in 1% (Table 2).
For the overall population including DCA and PCI,
ﬂuoroscopy at 7.5 FPS, compared with 15 FPS, was asso-
ciated with a signiﬁcant reduction in operator dose (30%
relative reduction [RR], p < 0.0001) and signiﬁcant
reduction in patient’s DAP (19% RR, p ¼ 0.022) (Table 2).
When stratiﬁed by procedural type, ﬂuoroscopy time was
similar in 7.5 FPS and 15 FPS ﬂuoroscopy groups for
DCA (p ¼ 0.42) and PCI (p ¼ 0.57) (Table 3). However,
ﬂuoroscopy at 7.5 FPS, compared with 15 FPS, was asso-
ciated with a signiﬁcant reduction in operator dose during
both DCA (RR 40%, p < 0.0001) and PCI (RR 28%,p ¼ 0.0011) (Table 3, Fig. 3). Furthermore, ﬂuoroscopy at
7.5 FPS was also associated with signiﬁcant reduction in
the patients’ DAP during DCA (RR 26%, p ¼ 0.0018). In
addition, 7.5 FPS, compared with 15 FPS, was associated
with a trend in reduction in the patients’ DAP during
PCI (RR 19%, p ¼ 0.13) (Table 3, Fig. 4).
Discussion
This is the ﬁrst randomized trial to examine an effective, yet
simple method of reducing radiation exposure by using low
rate ﬂuoroscopy at 7.5 FPS during cardiac catheterization via
TRA. The present study demonstrates a substantial and
clinically meaningful reduction in patient and operator dose
during diagnostic angiography and PCI using the low rate
ﬂuoroscopy. This effect comes at no difference in ﬂuoros-
copy time, procedural duration, or contrast volume between
7.5 FPS and conventional 15 FPS.
Supported by a large body of evidence and enhanced by
technological and procedural advances, there has been a sig-
niﬁcant expansion in the x-ray–guided cardiac interventional
procedures over the past few years (21). Although these
Table 1. 7.5 Versus 15 FPSdBaseline Characteristics
All
(N ¼ 363)
7.5 FPS
(n ¼ 182)
15 FPS
(n ¼ 181) p Value
Age, yrs 65  11 66  10 65  12 0.82
Male 254 (70) 121 (66) 133 (73) 0.17
Height, cm 168  10 168  10 168  10 0.98
Weight, kg 81  17 81  18 81  17 0.84
BMI, kg/m2 28.6  5.6 28.5  5.7 28.8  5.6 0.65
Diabetes 99 (28) 55 (31) 44 (25) 0.29
Hypertension 247 (70) 127 (71) 120 (69) 0.64
Hypercholesterolemia 257 (73) 128 (72) 129 (74) 0.81
Smoking history 75 (21) 40 (22) 35 (20) 0.60
Creatinine, mmol/l 89  31 87  29 92  33 0.080
Prior radial access 112 (32) 56 (31) 56 (32) 0.91
Prior PCI 80 (23) 40 (22) 40 (23) 0.90
Prior CABG 23 (6) 9 (5) 14 (8) 0.29
Procedural indication 0.70
Stable angina 114 (31) 57 (31) 57 (31)
Unstable angina 80 (22) 46 (25) 34 (19)
NSTEMI 85 (23) 38 (21) 47 (26)
STEMIdprimary 31 (9) 16 (9) 15 (8)
STEMIdrescue 12 (3) 6 (3) 6 (3)
Other 41 (11) 19 (10) 22 (12)
Values are mean  SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft; FPS ¼ frames per second;
PCI ¼ percutaneous coronary intervention; NSTEMI ¼ non–ST-segment elevation myocardial
infarction; STEMI ¼ ST-segment elevation myocardial infarction.
Table 2. 7.5 Versus 15 FPSdProcedural Characteristics
All
(N ¼ 363)
7.5 FPS
(n ¼ 182)
15 FPS
(n ¼ 181) p Value
Operator 0.39
Fellow 325 (90) 160 (88) 165 (91)
Staff 38 (10) 22 (12) 16 (9)
First access 0.86
RRA 330 (91) 166 (91) 164 (91)
LRA 33 (9) 16 (9) 17 (9)
Catheter size, % 0.34
4-F 18 (5) 11 (6) 7 (4)
5-F 231 (64) 109 (60) 122 (67)
6-F 113 (31) 61 (34) 52 (29)
7-F 1 (0.3) 1 (0.5) 0 (0)
Procedural type 0.68
DCA 174 (48) 85 (47) 89 (49)
PCI 179 (49) 93 (51) 86 (48)
Graft restudy 10 (3) 4 (2) 6 (3)
LV angiography 164 (45) 85 (47) 79 (44) 0.60
Aortography 17 (5) 7 (4) 10 (6) 0.47
PCIdtreated vessels, n 0.89
1 108 (60) 56 (60) 52 (60)
2 59 (33) 30 (32) 29 (34)
3 12 (8) 7 (8) 5 (6)
PCIdlesion type
Patients with 1 B2/C
lesion
104 (58) 54 (58) 50 (58) 1.00
PCIdExtra
Bifurcation PCI 37 (19) 21 (21) 16 (17) 0.4713
CTO PCI 14 (7) 7 (7) 7 (8) 1.000
IVUS 5 (3) 2 (2) 3 (3) 0.68
FFR 22 (12) 8 (8) 14 (15) 0.17
Stents implanted, n 1.8  1.1 1.8  1.1 1.8  1.1 0.91
Catheters used, n 3.0  0.7 3.1  0.7 3.0  0.8 0.83
Procedural duration, min 32  23 31  21 32  26 0.92
Contrast volume, ml 107  55 110  54 104  55 0.22
Fluoroscopy time, min 8.1  8.2 7.7  7.5 8.4  8.8 0.87
Dose-area product, Gy$cm2 48  37 43  30 54  43 0.022
36 (22–62) 34 (21–56) 38 (25–66)
Operator radiation dose, mSv 40  34 34  30 48  37 <0.0001
30 (18–54) 24 (14–44) 36 (22–62)
Values are n (%), mean  SD, or median (interquartile range).
CTO ¼ chronic total occlusion; DCA ¼ diagnostic coronary angiography; FFR ¼ fractional
ﬂow reserve; IVUS ¼ intravascular ultrasound; LRA ¼ left radial artery; LV ¼ left ventricular;
RRA ¼ right radial artery; other abbreviations as in Table 1.
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571interventions offer immense beneﬁts to patients, their
growing use also contributes signiﬁcantly to radiation expo-
sure for patients and constitutes a signiﬁcant occupational
hazard to medical personnel (22–24). Today, mean DAP
between 16 and 106 Gy$cm2 for diagnostic angiography
and between 34 and 109 Gy$cm2 for PCI have been
reported (25).
Reducing radiation exposure for both patients and oper-
ators is a universal goal. Concerns have been raised over
possible increased operator and patient radiation exposure
with TRA in small randomized and observational studies
(7–10). However, some previous reports on radiation
exposure between TRA and TFA suffered signiﬁcant limi-
tations as they were performed during operator learning
curve, derived from low- to intermediate-volume radial
centers (10,11), or had important methodological ﬂaws such
as nonuniform operator shielding (7) or variable technical
expertise between TFA and TRA operators (26,27). Recent
evidence from small controlled studies suggests equal radi-
ation exposure for experienced TRA and TFA operators
(19). Although evidence of increased radiation exposure
with TRA remains inconclusive, published data so far in its
totality suggests an increase in ﬂuoroscopy time and radia-
tion exposure with TRA (28).
In the radiation substudy of RIVAL (Radial Versus
Femoral Access for Coronary Intervention), there was anominal overall increase in radiation dose with radial versus
femoral access, but differences were observed only in lower-
volume centers and operators (18). Although ﬂuoroscopy
time diminishes with expertise, this was consistently higher
for radial versus femoral access across all subgroups (18).
This persistent difference despite improvement in expertise
could be explained by the frequent need to navigate technical
and anatomical challenges with TRA.
On average, patient radiation exposure during DCA
corresponds to approximately 300 and during PCI to 1,000
Table 3. Radiation Measurements and Endpoints Stratiﬁed by Procedural Type
DCA (n ¼ 184) PCI (n ¼ 179)
7.5 FPS
(n ¼ 89)
15 FPS
(n ¼ 95) p Value
7.5 FPS
(n ¼ 93)
15 FPS
(n ¼ 86) p Value
Primary endpoints
Operator radiation dose, mSv 21  17
18 (10–25)
35  29
24 (17–45)
<0.0001 45  34
36 (22–66)
63  40
52 (35–87)
0.0011
Patient DAP, Gy$cm2 25  15
23 (15–31)
34  25
29 (18–40)
0.0018 61  31
55 (35–83)
75  48
59 (38–118)
0.13
Fluoroscopy time, min 3.4  2.0
2.6 (1.8–4.5)
4.0  4.7
2.9 (1.9–4.4)
0.42 11.9  8.4
9.2 (5.7–15.0)
13.3  9.7
11.0 (5.2–19.5)
0.57
Secondary endpoints
Procedural duration, min 18  7
17 (13–21)
18  11
15 (13–20)
0.91 43  22
37 (28–57)
48  28
43 (28–61)
0.33
Contrast volume, ml 76  29
70 (63–88)
77  35
70 (60–90)
0.99 142  53
130 (100–178])
133  57
130 (80–175)
0.18
Values are mean  SD or median (interquartile range).
DAP ¼ dose-area product; DCA ¼ diagnostic coronary angiography; other abbreviations as in Table 1.
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572chest x-rays (16). From a patient’s perspective, although 20%
reduction in DAP by using low rate ﬂuoroscopy during
TRA procedures may not alter overall radiation risk for a
single procedure, this magnitude of reduction may be sub-
stantial for complex procedures and cumulative for repeat
procedures. In addition, diminishing patient radiation
exposure is an important way of reducing scatter radiation to
staff (29).
For interventional cardiologists, a 20% relative reduc-
tion in operator dose with low rate ﬂuoroscopy during DCA
and PCI, respectively, is clearly substantial, saving approxi-
mately 6 years of radiation exposure over a 30-year career. It
has been estimated that for high-volume operators, with
yearly occupational exposure of 5 mSv, the lifetime extra risk
for fatal or nonfatal cancer is around 1:100 (16). Although
difﬁcult to quantify, a 28% to 40% reduction in operatorFigure 3. Effect of 7.5 FPS on Operator Radiation Dose
Fluoroscopy at 7.5 FPS resulted in signiﬁcant reduction in operator dose
during DCA and PCI. Abbreviations as in Figure 2.radiation exposure is likely to signiﬁcantly alter this risk. In
addition, it has been estimated that trainees receive 60%
more radiation in their ﬁrst year of training than in their
second year, presumably due to longer ﬂuoroscopy time to
position catheters. Therefore, and with the expected surge in
adoption of TRA, it is crucial to implement all possible
measures to reduce operator and patient radiation exposure
during TRA procedures. Although reducing FPS could be
associated with less temporal resolution (hence lower image
quality), this was not the case in our study as evidenced by
the similar ﬂuoroscopy and procedural times.
A unique feature of the current study is that it reﬂects
results from a contemporary high-volume radial center
during everyday practice via TRA in an unselected cohort.
Our study adds to published reports on potential ways of
reducing radiation exposure during TRA practice. The useFigure 4. Effect of 7.5 FPS on Patient DAP
Signiﬁcant reduction in patient dose-area product (DAP) with low rate
ﬂuoroscopy during DCA. Abbreviations as in Figure 2.
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573of a disposable lead-free radiation shield drape (30), a
dedicated “transradial protection board” (31), pelvic lead
shielding (32), or enhanced lead shielding (33) have all been
shown to reduce operator radiation exposure during pro-
cedures. However, this approach is unique, simple, and,
importantly, cost-free, and adds to the armamentarium
available to radial operators to reduce radiation exposure.
Although there are no published limits to radiation exposure
per cardiac procedure, it remains the primary responsibility
of all physicians to reduce hazard of radiation injury to their
patients, other professional staff, and themselves (34,35).
Study limitations. This is a single-center study with a long-
standing experience with radial approach. Keeping with
the as low as reasonably achievable principles, this study was
part of a continuous quality control program to minimize
radiation exposure to patients and staff. Hence, we cannot
exclude that operators took extra care to reduce radiation
exposure during the study conduct. We chose this design to
assess efﬁcacy of this simple approach in daily practice. The
unselected cohort and randomized design are major
strengths. Approximately 10% of our cases were performed
via LRA, but these were equally distributed between the
2 randomization groups. We did not observe a signiﬁcant
difference in radiation measures between the 2 approaches
(data not shown). Lastly, the beneﬁt of dose reduction with
lower frame-rate is not expected to be limited to TRA and
should also apply to the femoral approach, hence the
magnitude should be assessed in a speciﬁcally designed study
with femoral approach.
Conclusions
Low rate ﬂuoroscopy at 7.5 FPS offers a simple, cost-free,
yet a very effective measure to reduce both operator and
patient radiation exposure during TRA in real-world situa-
tions, without any effect on procedural duration, ﬂuoroscopy
time, or contrast use. We suggest that operators should
routinely adopt this method to minimize radiation exposure.
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